Back

Is empagliflozin still cardioprotective in SGLT2 KO mice?

28 August 2022 (09:00 - 09:15)
Organised by:
Congress Presentation Part of: Basic and Translational Late-Breaking Science 1 Ischaemia, Infarction, Cardioprotection ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Miss Sha Chen

AMC Medical Research BV, Amsterdam (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Intravascular administration of soluble Sars-CoV-2 Spike protein triggers non-infective heart and lung inflammation and vascular pericytes rarefaction in healthy mice.
Doctor E. Avolio (Bristol, GB)
Slides Video
Presentation thumbnail
CRISPR/Cas9 editing of CaMKII as a strategy for cardioprotection against ischemia/reperfusion injury.
Professor S. Lebek (Regensburg, DE)
Slides Video
Presentation thumbnail
Plasma of COVID-19 positive patients promote oxidative stress and proinflammatory responses in endothelial cells: Potential role of the pro-inflammatory cytokines/SGLT2 pathway.
Doctor A. Mroueh (Strasbourg, FR)
Slides Video

Access the full session

Session thumbnail
Basic and Translational Late-Breaking Science 1
Video

The Event

Event poster

ESC Congress 2022

28 August 2022 09:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources